RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Medi-patch With Lidocaine (NDC 76074-153) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This formulation is linked to a unique clinical concept (RxCUI 1356803). By anchoring Two Hip Consulting, Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
Type
Clinical Name / Synonym
RxCUI
Details
Featured Concept
capsaicin 0.00035 MG/MG / lidocaine hydrochloride 0.005 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Medicated Patch
(RxCUI 1356803)
Semantic Clinical Drug
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
Understanding RxNorm Mapping for Medi-patch With Lidocaine RX
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 76074-153 to RxCUI 1356803, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
-
PSN
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
-
SCD
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
-
SY
Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
* Please review the full disclaimer at the bottom of this page.